Patents

RECENT NEWS
Automotive World  Jan 21  Comment 
Automotive World speaks with Patent Analyst Bob Stembridge on some of the forces at work behind automotive patent activity and the key players to look out for moving forward The post Patent activity – which companies and technologies are...
The Economic Times  Jan 21  Comment 
US Supreme Court sends patent case back to lower court. Generic launches by Natco and other pharma companies will be delayed, say analysts.
Wall Street Journal  Jan 20  Comment 
The U.S. Supreme Court reversed an appeals court ruling that invalidated a Teva patent on the blockbuster multiple-sclerosis drug Copaxone, giving the drug maker an opportunity to block generic rivals.
TechCrunch  Jan 20  Comment 
 Apple has been granted a patent (via AppleInsider) that describes a method for tracking eye movement and using it to control UI elements on computing devices. The gaze-based control system also includes methods designed to counteract visual...
The Hindu Business Line  Jan 20  Comment 
Pharmaceutical firm Suven Life Sciences has been granted four product patents — one each by Australia and Hong Kong and two by Japan for treatment of neurodegenerative diseases. Neurodege...
The Hindu Business Line  Jan 16  Comment 
Terming patents as a “scourge” on the software industry, Infosys CEO Vishal Sikka has said his company is “rethinking” its approach on the subject.With roots in software products industry,...
The Hindu Business Line  Jan 16  Comment 
California headquartered Gilead Sciences will appeal the Indian patent office decision to reject a patent application that covers Hepatitis C drug sofosbuvir. Earlier this week, the Indi...
The Hindu Business Line  Jan 15  Comment 
In the first significant patent decision this year, the Indian Patent Office has rejected one of the patent applications covering US drug-maker Gilead’s hepatitis C drug Sofosbuvir.  
The Economic Times  Jan 14  Comment 
"I am concerned about the fact that domestic filings of patent applications have remained static in the past few years at about 20 per cent of the overall filings," Kant said.




 
TOP CONTRIBUTORS

Patents

Patent is the right to ownership,as part of an intellectual property law, where by a person / organization discovers a lesser known concept or invents something new and holds sole intellectual ownership rights to that particular idea. These are usually published / granted after a lot of research and exhaustive verification. Patents are generally registered with United States Patent and Trademark Office, an Agency Of The United States Department Of Commerce, in the United States and The Intellectual Property Office,a division of the Department for Innovation, Universities & Skills in the United Kingdom.

Technological Patents

Pharmaceutical Patents

Pharmaceutical patents protect manufacturers of prescription drugs, prohibiting others from producing a drug during the length of its patent protection. The length of these patents varies in different countries, though they are usually between 15-20 years. In the U.S., a pharmaceutical patent is valid for 20 years. Drug companies usually apply for patent protection before they actually begin producing the drug, opting instead to secure their rights to a particular compound at the beginning of the testing process. By the time a drug comes to market, there may only be 8-10 years of patent protection remaining, which is significantly less than the 20 offered by the patent. Companies often attempt to extend these patents by making slight reformulations of the original compound or proving its effectiveness at treating a condition other than the one for which it was originally granted a patent. This is referred to as "evergreening", a practice which many criticize.

For further information on the process of obtaining pharmaceutical patents and regulatory approval, see Clinical Trials and FDA Approval.

For more information about pharmaceutical patents in relation to generic versions of drugs, see Generic Drugs.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki